*This news is NOT investment advice. It’s for educational purposes only.*
Mid-Week Update: k
Trulieve & Verano Q3: U
Curaleaf Q3: M
Green Thumb, Cresco, Columbia Care Q3: A
Correction @20:16 Meant to Say Public Sector, Not Private. Word Fart My Bad.
Timecodes:
00:00 – Intro
00:40 – Twitter Spaces with Curaleaf Chairman Boris Jordan, 45 mins of Insight
5:10 – NCV Article: Why Canna Investors Are Wrong to Fear MSOS Out of Cash
5:50 – Congressional Dems Announce New 2022 Plan to Push MORE, SAFE, Research
8:15 – One Year Later, Promises Unfulfilled, MPP CEO Says Told Reform, Expect It
9:15 – Vice Covering Another CBD Study: Oral CBD May Help Prevent C19 Infection
10:46 – More Evidence for CBD as an Exit Drug From Science Direct
12:00 – NBC Covering Massive Tax Influx From Recreational States in 2021
12:40 – Trulieve and Harvest Celebrate AZ’s First Year of Legal Sales
13:51 – Curaleaf Closes Bloom Acquisition, Opens 2 New Dispensaries in PA
15:00 – More Info on Cresco Labs and Whiz Khalifa Partnership
15:45 – FL Adds 2,936 Patients, Strong Sales
16:15 – New Mexico Doubles Legal Plant Count Ahead of Adult Use Launch April 1
16:56 – MS House Approves Medical Legalization Bill With Amendments
17:39 – Bipartisan Senators in PA File Cannabis Banking Protection Bill
18:36 – SC Medical Legalization Bill, Will Be on Floor Next Week
19:29 – RI Governor Adds Legalization & Expungements to Budget Request For 4/2023
20:07 – NJ Update – Feb 22 Launch Doubtful – Correction @20:16 Public, Not Private
21:34 – Lawsuit Stalls GA Medical Market Launch
22:17 – Kansas Medical Cannabis Hearings Were Cancelled – Damn
23:01 – Italy Update: Referendum Vote for Legalization Expected Early 2022, No Date
23:45 – BBG Intelligence via Todd Harrison – EU Cannabis and the German Market
24:15 – Canadian Retail Sales Fall in November to $353M, Ontario Still Seeing Growth
25:15 – Growing Number (58%) of Canadian Consumers Transition to Licit Market
Sources:
7
/>
t
/
s
7
1
/>
/
s
/
f
/
/
/
/
/
s
/
/
/>
4
/>
e
2
Disclaimer**This is not investment advice. It is educational and informative entertainment to help people learn new investing perspectives that they can compare with their own. Invest at your risk. **
